|
|
 |
| |
| Thermo Fisher Scientific Acquires OptiCell Product Line |
| Expanded market development planned for next generation cell culture technology |
| |
Rochester, New York (July 5, 2007) – Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has acquired all assets of the OptiCell product line from BioCrystal Ltd. Of Westerville, OH. Included in the transaction were trademarks, production equipment, inventory, and 12 patents associated with the OptiCell technology. “We believe OptiCell film technology holds great promise for improving the effectiveness and productivity of cell culture work,” said Steve Silverman, Thermo Fisher Vice President and General Manager, Labware and Specialty Plastics, NALGENE® and NUNC™ Products.
During the past year, OptiCell products were marketed by Nalge Nunc International (NNI) under an exclusive worldwide distribution agreement with BioCrystal. “This acquisition helps us leverage and further develop OptiCell as a next generation cell culture device. Former OptiCell R&D and Product Manager, Dr. Cindy Neeley, will provide applications support and participate in further product development. “We are very pleased that Nalge Nunc International, a worldwide leader in cell culture technology development, has made this commitment to build on the promise that OptiCell offers for the medical life science community,” added Jeff Bergen, BioCrystal CEO. |
| |
| Invitrogen Corporation Acquires Fluorescent Nanocrystal Business Unit from BioCrystal, Ltd. |
| |
COLUMBUS OH (October 6, 2005) – BioCrystal, Ltd., today announced that Invitrogen Corporation (Nasdaq: IVGN), a life science company providing innovative technologies to support disease research and improving the human condition, has acquired the assets of the BioPixelsTM Business Unit of BioCrystal, Ltd. This acquisition is part of a long term strategy to solidify Invitrogen’s Molecular Probes business as the market leader in labeling and detection technologies. |
| |
| Invitrogen intends to create new innovative products that enable life science researchers to better visualize and understand cellular processes, DNA mutations, and other factors essential to diagnosing and treating disease. “Invitrogen’s Molecular Probes business is the market leader in organic synthesis-based labeling and detection technologies,” said Augie Sick, General Manager of Molecular Probes. “This acquisition is part of a robust platform for product development based on semiconductor nanotechnologies for labeling and detection.” |
| |
BioCrystal, Ltd., has developed novel coatings and metal alloys for semiconductor nanocrystals, called BioPixelsTM, have been applied to multicolor labeling, sorting and imaging of cells, lateral flow immunoassays and fluorescent inks, and represent a promising technology for the development of automated assays of complex biological samples. “We are very pleased to know that our fluorescent nanocrystal technology will play an important role for Invitrogen in growing their fluorescent detection business,” added Jeff Bergen, CEO of BioCrystal. |
| |
 |
|
